Skip to main content

Find Clinical Trials

Home
Conditions
Whooping Cough

Clinical trial condition

Whooping Cough

Explore clinical trials studying Whooping Cough. Study availability and eligibility vary by location and protocol.

231 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Whooping Cough trial results

Completed

Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects

NCT00317109

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +23 more
Locations: GSK Investigational Site Brits, South Africa

GSK Investigational Site Ga-Rankuwa, South Africa

GSK Investigational Site Rooihuiskraal, South Africa

View Trial Details

Completed

Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study

NCT00291343

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +23 more
Locations: GSK Investigational Site Manila, Philippines

GSK Investigational Site Sampaloc, Manila, Philippines

View Trial Details

Completed

Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)

NCT00432042

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +53 more
Locations: Alsfeld, Germany

Bad Saulgau, Germany

Bad Säckingen, Germany

Bad Sobernheim, Germany

View all 50 locations

View Trial Details

Completed

The Feasibility of Pertussis Immunization in a Canadian Emergency Department

NCT03304275

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +10 more
Locations: Queen Elizabeth Hospital Charlottetown, Prince Edward Island, Canada

View Trial Details

Completed

A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine

NCT03137927

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +5 more
Locations: Infectious Disease Clinical Hospital No. 1 of the Moscow Healthcare Department Moscow, Russia

View Trial Details

Completed

TDAP Safety in Pregnant Women

NCT02209623

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +6 more
Locations: Duke University Dept of ObGyn, Division of Maternal-Fetal Medicine Durham, North Carolina, United States

Vanderbilt Medical Center, Vaccine Research Program Nashville, Tennessee, United States

View Trial Details

Completed

A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' Assays

NCT02072525

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations: GSK Investigational Site Sherbrooke, Quebec, Canada

View Trial Details

Completed

Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish Children

NCT01583049

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations: Centre 11 Almería, Spain

Centre 12 Almería, Spain

Centre 13 Almería, Spain

Centre 14 Almería, Spain

View all 22 locations

View Trial Details

Completed

Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older

NCT01287949

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations: Sanofi Pasteur MSD investigational site Clermont-Ferrand, France

Sanofi Pasteur MSD investigational site Lille, France

Sanofi Pasteur MSD investigational site Montpellier, France

Sanofi Pasteur MSD investigational site Paris, France

View Trial Details

Completed

Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old

NCT01249183

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations: Sanofi Pasteur MSD Investigational Site Angers, France

Sanofi Pasteur MSD Investigational Site Châtellerault, France

Sanofi Pasteur MSD Investigational Site Clermont-Ferrand, France

Sanofi Pasteur MSD Investigational Site Gières, France

View all 20 locations

View Trial Details